Person profile
Public information reviewed
Mark Enyedy
Board role
Independent Director · Charles River Laboratories (NYSE: CRL)
Board role
Director · BIOMARIN PHARMACEUTICAL INC (NASDAQ: BMRN)
Charles River Laboratories (NYSE: CRL)
Independent Director · Current mandate
Director · Board
- Public sources
- 4 reviewed
- Profile ownership
- Not yet claimed
- Last reviewed
- May 16, 2026

